Blood Testing

This channel includes news and new technology innovations for blood testing including platelet function monitors.

Siemens Healthineers Showcases New In Vivo and In Vitro Cardiovascular Solutions at TCT 2018
News | Cardiac Diagnostics | September 21, 2018

September 21, 2018 — At the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference, Sept. 21-25 in San...

AI-Driven Blood Test Accurately Diagnoses Peripheral Artery Disease in Diabetic Patient
News | Blood Testing | September 04, 2018

September 4, 2018 — Prevencio Inc. announced new data demonstrating its HART PAD test accurately diagnoses...

More Sensitive Blood Test Diagnoses Heart Attacks Faster
News | Blood Testing | August 06, 2018

August 6, 2018 — A new test to assess a whether or not someone is having a...

Siemen's Atellica IM high-sensitivity troponin I assay (TnIH).
Technology | Cardiac Diagnostics | July 25, 2018

July 25, 2018 — The U.S. Food and Drug Administration (FDA) cleared Siemens Healthineers high-sensitivity troponin I...

Singulex cTnl Assay Can Identify Presence, Severity of CAD in Stable, Symptomatic Outpatients
News | Blood Testing | March 26, 2018

March 26, 2018 — Measurement of cardiac troponin in stable patients with chest pain using the ultra-sensitive...

Videos | Cardiac Diagnostics | March 26, 2018

James Januzzi, M.D., Roman W. DeSanctis Endowed Distinguished Clinical Scholar in Medicine, and director of the...

The Corus CAD genetic test is a simple, noninvasive blood test that is clinically available for the assessment of obstructive coronary artery disease.

The Corus CAD gene expression test is a simple, noninvasive blood test that is available to assess a patient’s current likelihood of having obstructive coronary artery disease (CAD).

 

Feature | Genetic Testing | December 13, 2017 | Andrew Waxler, M.D., FACC

The diagnosis and management of cardiovascular disease has long followed a familiar approach. Patients see their...

The Role of Telomere Length in Cardiovascular Risk Assessment
Feature | Cardiac Diagnostics | October 19, 2017 | Nanette H. Bishopric, M.D., FACC, FAHA

A new area of DNA testing involving telomere length may enhance a patient’s cardiovascular disease risk...

Florida Medical Center First in State to Offer High Sensitive STAT Blood Test
News | Blood Testing | September 07, 2017

September 7, 2017 — In July, The Heart Institute at Florida Medical Center became the first hospital in the state of...

Alere point of care POC testing for INR
News | Point of Care Testing | July 17, 2017 | Dave Fornell

July 17, 2017 — Despite issues with point-of-care INR testing company Alere Inc., Abbott announced this week it is...

Siemens Xprecia Stride anticoagulation, coagulation PT/INR or INR testing at the point of care (POC)

Point-of-care coagulation PT/INR testing with handheld devices can help improve outcomes with more convenient and frequent measurements to keep patients within the therapeutic range of anticoagulant agents.

Feature | Point of Care Testing | May 05, 2017 | Nicholas C. Vanderslice, Ph.D., and Arnol S. Rios

Point-of-care (POC) coagulation analyzers that measure prothrombin time/international normalized ratio (PT/INR) on...

Patients With Low Corus CAD Test Score Less Likely to Undergo Cardiac Referra
News | Blood Testing | May 02, 2017

May 2, 2017 — CardioDx Inc. recently announced the publication of results from the multi-center, community-based...

New Blood Test Predicts Major Cardiac Events Better Than Clinical Evaluation of Other Common Risk Factors
News | Blood Testing | April 28, 2017

April 28, 2017 — Prevencio Inc. announced the publication of data demonstrating that a simple new...

New Study Pursues Universal Sample Bank for Troponin Tests
News | Blood Testing | April 13, 2017

April 13, 2017 — A study published recently in the American Association for Clinical Chemistry’s (AACC)...

PTS Diagnostics, FDA 510k clearance, extended HDL range, lipid panel test strips
News | Blood Testing | April 05, 2017

April 5, 2017 — PTS Diagnostics announced that the U.S. Food and Drug Administration (FDA) has cleared an expanded...

Overlay Init